Stanford University professor James Zou is fundraising for Human Intelligence at a ~$1 billion valuation. The startup aims to use artificial intelligence to study human physiology.
Zou, a computer science professor at Stanford, is seeking approximately $100 million in funding for the venture, according to sources cited by Bloomberg.
Human Intelligence focuses on developing AI models designed to advance understanding of how the human body functions at a physiological level. The approach leverages machine learning to analyze biological systems and processes.
The $1 billion valuation places Human Intelligence among a growing cohort of AI-focused biotech startups gaining significant investor interest. The funding round reflects broader momentum in applying large language models and neural networks to healthcare and life sciences research.
Zou has established credentials in AI research and its applications to biology. His work at Stanford has centered on machine learning methods for understanding complex biological data.
The fundraising effort comes as venture capital continues flowing toward AI companies addressing specific scientific and medical challenges. Human Intelligence's focus on physiology positions it within the intersection of computational biology and generative AI.
Chip design startup Agentrys raised $24.5 million across two rounds, combining a $19.1M seed led by Etna Labs and a $5.4M pre-seed backed by MediaTek. The Nvidia-founded company develops a platform for creating custom agents.
Liux, a startup manufacturing its Big microcar in Spain, is entering the crowded electric vehicle market with a sustainability-focused approach. The company aims to compete against established Chinese rivals through eco-conscious design and manufacturing.
Minneapolis-based workforce monitoring startup Yardstik closed a $30M Series B funding round led by Harbert Growth Partners. The round brings the company's total funding to $65M.
Retro, a friend-focused photo-sharing app founded by former Instagram employees, has secured $21 million in Series A funding. The capital injection signals investor confidence in the social app's differentiated approach to photo sharing.